Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 487 for sleep

Edit search filters
  1. A Study to Evaluate the Safety, Tolerability and Effectiveness of V117957 in Subjects with Insomnia Associated with Alcohol Cessation

    Rochester, MN

  2. A Study To Assess The Effectiveness And Safety Of AF-219 For Subjects With A Treatment Resistant Chronic Cough

    Rochester, MN

  3. Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial 

    Rochester, MN

  4. A Study To Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) For Extensive Stage Small Cell Lung Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, La Crosse, WI, Rochester, MN

  5. Lung Volume Reduction Coil Treatment In Patients With Emphysema (RENEW) Study

    Rochester, MN

  6. A Study Of The Safety And Effectiveness Of Inhaled Mannitol For Adult Patients With Cystic Fibrosis

    Rochester, MN

  7. Bentracimab (PB2452) In Ticagrelor-treated Patients With Uncontrolled Major Or Life-Threatening Bleeding Or Requiring Urgent Surgery Or Invasive Procedure

    Jacksonville, FL

  8. Sacituzumab Tirumotecan (MK-2870) In Combination With Pembrolizumab Versus Pembrolizumab Alone In Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations

    Rochester, MN

  10. A Study Of The Treatment Of Septic Shock By Inhibiting Autodigestion And Preserving Gut Integrity With Enteric LB1148

    Rochester, MN

.

Mayo Clinic Footer